A Kaneka company, AB-BIOTICS is back with the latest patented, clinically proven probiotic strains in the form of consumer food favourites and novelties, including cookies.
The company will also share the latest research on fermented probiotic juices, highlighting the strain’s ability to support immune health and its other health benefits.
Setting stability standards
On stand 4.0G64, AB-BIOTICS will spotlight B. coagulans Unique IS-2, a new clinically tested probiotic strain that aims to raise the bar for stability across food applications — even under a wide range of temperatures and extreme processing conditions.
Unlike many others, this probiotic strain boasts high stability and resilience, allowing manufacturers to incorporate it into a wide variety of processed food applications.
Backed by more than 25 clinical studies, B. coagulans Unique IS-2 has been shown to support digestive health, enhance protein absorption and boost immunity, in line with growing consumer demands for functional foods.
Experts will be on-stand to explain the benefits of B. coagulans Unique IS-2 in more detail, including how its natural encapsulation enables a high survivability rate in stomach acid and bile juices, to reach the intestine, where it colonises.
Its resistance to a greater range of temperatures — from high boiling to low freezing — means it is a valued addition to varying formats, such as gummies, tablets, dry powders, beverages and finished food products.
Uncovering research on fermented juices
For a more in-depth look at probiotics, AB-BIOTICS will also be presenting recent research exploring the ability of the probiotic strain L. Plantarum DR7 to ferment orange, apple and peach juices.
Francesca Rizzi, Food Application Specialist at AB-BIOTICS, will discuss the findings from the research, including the strain’s stability in different juices and the production of bioactive compounds owing to fermentation.